Advertisement

Biophysical Reviews

, Volume 10, Issue 2, pp 259–269 | Cite as

Sedimentation velocity analytical ultracentrifugation for characterization of therapeutic antibodies

  • Susumu Uchiyama
  • Masanori Noda
  • Elena Krayukhina
Review

Abstract

Sedimentation velocity analytical ultracentrifugation (SV-AUC) coupled with direct computational fitting of the observed concentration profiles (sedimentating boundary) have been developed and widely used for the characterization of macromolecules and nanoparticles in solution. In particular, size distribution analysis by SV-AUC has become a reliable and essential approach for the characterization of biopharmaceuticals including therapeutic antibodies. In this review, we describe the importance and advantages of SV-AUC for studying biopharmaceuticals, with an emphasis on strategies for sample preparation, data acquisition, and data analysis. Recent discoveries enabled by AUC with a fluorescence detection system and potential future applications are also discussed.

Keywords

Analytical ultracentrifugation Sedimentation velocity Biopharmaceuticals Protein Aggregates Immunogenicity 

Notes

Acknowledgements

This work was partly supported by the MEXT/JSPS Grants in Aid for Scientific Research (15 K14457, 17H03975) and by grant-in-aid from the Research on Development of New Drugs of AMED.

Compliance with ethical standards

Conflict of interest

Susumu Uchiyama declares that he has no conflicts of interest. Masanori Noda declares that he has no conflicts of interest. Elena Krayukhina declares that she has no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. Abbas A, Lichtman AH, Pillai S (2017) Hypersensitivity disorders. In: Cellular and molecular immunology, 9th edn. Elsevier, pp 417–437Google Scholar
  2. Arakawa T, Philo JS, Ejima D, Tsumoto K, Arisaka F (2007) Aggregation analysis of therapeutic proteins, part 2. Analytical ultracentrifugation and dynamic light scattering. Bioproc Int 5:36–47Google Scholar
  3. Arakawa T, Ejima D, Li T, Philo JS (2010) The critical role of mobile phase composition in size exclusion chromatography of protein pharmaceuticals. J Pharm Sci 99:1674–1692.  https://doi.org/10.1002/jps.21974 CrossRefPubMedGoogle Scholar
  4. Arthur KK, Gabrielson JP, Kendrick BS, Stoner MR (2009) Detection of protein aggregates by sedimentation velocity analytical ultracentrifugation (SV-AUC): sources of variability and their relative importance. J Pharm Sci 98:3522–3539.  https://doi.org/10.1002/jps.21654 CrossRefPubMedGoogle Scholar
  5. Attri AK, Minton AP (2005) Composition gradient static light scattering: a new technique for rapid detection and quantitative characterization of reversible macromolecular hetero-associations in solution. Anal Biochem 346:132–138.  https://doi.org/10.1016/j.ab.2005.08.013 CrossRefPubMedGoogle Scholar
  6. Berkowitz SA (2006) Role of analytical ultracentrifugation in assessing the aggregation of protein biopharmaceuticals. AAPS J 8:E590–E605.  https://doi.org/10.1208/aapsj080368 CrossRefPubMedPubMedCentralGoogle Scholar
  7. Berkowitz SA, Philo JS (2015) Characterizing biopharmaceuticals using analytical ultracentrifugation. In: Houde DJ, Berkowitz SA (eds). Biophysical characterization of proteins in developing biopharmaceuticals. Elsevier, Amsterdam, pp 211-260. doi: https://doi.org/10.1016/b978-0-444-59573-7.00009-9
  8. Carpenter JF, Randolph TW, Jiskoot W, Crommelin DJ, Middaugh CR, Winter G (2010) Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products. J Pharm Sci 99:2200–2208.  https://doi.org/10.1002/jps.21989 CrossRefPubMedGoogle Scholar
  9. Carpenter JF, Bain DL, Johnson GR (2016) Use of analytical ultracentrifugation as an orthogonal method for size exclusion chromatography: assuring quality for therapeutic protein products and meeting regulatory expectations. In: Uchiyama S, Arisaka F, Stafford W, Laue T (eds) Analytical ultracentrifugation. Springer, Tokyo, pp 389–395CrossRefGoogle Scholar
  10. Chaturvedi SK, Ma J, Zhao H, Schuck P (2017a) Use of fluorescence-detected sedimentation velocity to study high-affinity protein interactions. Nat Protoc 12:1777–1791.  https://doi.org/10.1038/nprot.2017.064 CrossRefPubMedGoogle Scholar
  11. Chaturvedi SK, Zhao H, Schuck P (2017b) Sedimentation of reversibly interacting macromolecules with changes in fluorescence quantum yield. Biophys J 112:1374–1382.  https://doi.org/10.1016/j.bpj.2017.02.020 CrossRefPubMedPubMedCentralGoogle Scholar
  12. Cordes AA, Arthur KK, Gabrielson JP (2016) Biopharmaceuticals: application of AUC-SV for quantitative analysis of protein size distributions. In: Uchiyama S, Arisaka F, Stafford W, Laue T (eds) Analytical ultracentrifugation. Springer, Tokyo, pp 397–418CrossRefGoogle Scholar
  13. Correia JJ, Lyons DF, Sherwood P, Stafford W (2016) Techniques for dissecting the Johnston-Ogston effect. In: Uchiyama S, Arisaka F, Stafford W, Laue T (eds) Analytical ultracentrifugation. Springer, Tokyo, pp 483–498CrossRefGoogle Scholar
  14. Demeule B, Shire SJ, Liu J (2009) A therapeutic antibody and its antigen form different complexes in serum than in phosphate-buffered saline: a study by analytical ultracentrifugation. Anal Biochem 388:279–287.  https://doi.org/10.1016/j.ab.2009.03.012 CrossRefPubMedGoogle Scholar
  15. den Engelsman J, Garidel P, Smulders R, Koll H, Smith B, Bassarab S, Seidl A, Hainzl O, Jiskoot W (2011) Strategies for the assessment of protein aggregates in pharmaceutical biotech product development. Pharm Res 28:920–933.  https://doi.org/10.1007/s11095-010-0297-1 CrossRefGoogle Scholar
  16. Desai A, Krynitsky J, Pohida TJ, Zhao H, Schuck P (2016) 3D-printing for analytical ultracentrifugation. PLoS ONE 11:e0155201.  https://doi.org/10.1371/journal.pone.0155201 CrossRefPubMedPubMedCentralGoogle Scholar
  17. Doyle BL, Budyak IL, Rauk AP, Weiss WF (2017) An optical alignment system improves precision of soluble aggregate quantitation by sedimentation velocity analytical ultracentrifugation. Anal Biochem 531:16–19.  https://doi.org/10.1016/j.ab.2017.05.018 CrossRefPubMedGoogle Scholar
  18. Gabrielson JP, Arthur KK (2011) Measuring low levels of protein aggregation by sedimentation velocity. Methods 54:83–91.  https://doi.org/10.1016/j.ymeth.2010.12.030 CrossRefPubMedGoogle Scholar
  19. Gabrielson JP, Randolph TW, Kendrick BS, Stoner MR (2007) Sedimentation velocity analytical ultracentrifugation and SEDFIT/c(s): limits of quantitation for a monoclonal antibody system. Anal Biochem 361:24–30.  https://doi.org/10.1016/j.ab.2006.11.012 CrossRefPubMedGoogle Scholar
  20. Gabrielson JP, Arthur KK, Kendrick BS, Randolph TW, Stoner MR (2009) Common excipients impair detection of protein aggregates during sedimentation velocity analytical ultracentrifugation. J Pharm Sci 98:50–62.  https://doi.org/10.1002/jps.21403 CrossRefPubMedGoogle Scholar
  21. Gabrielson JP, Arthur KK, Stoner MR, Winn BC, Kendrick BS, Razinkov V, Svitel J, Jiang Y, Voelker PJ, Fernandes CA, Ridgeway R (2010) Precision of protein aggregation measurements by sedimentation velocity analytical ultracentrifugation in biopharmaceutical applications. Anal Biochem 396:231–241.  https://doi.org/10.1016/j.ab.2009.09.036 CrossRefPubMedGoogle Scholar
  22. Gonzalez JM, Rivas G, Minton AP (2003) Effect of large refractive index gradients on the performance of absorption optics in the Beckman XL-A/I analytical ultracentrifuge: an experimental study. Anal Biochem 313:133–136.  https://doi.org/10.1016/S0003-2697(02)00434-7 CrossRefPubMedGoogle Scholar
  23. Hill JJ, Laue TM (2015) Protein assembly in serum and the differences from assembly in buffer. Methods Enzymol 562:501–527.  https://doi.org/10.1016/bs.mie.2015.06.012 CrossRefPubMedGoogle Scholar
  24. Ishii-Watabe A, Shibata H, Harazono A, Hyuga M, Kiyoshi , Saitoh S, Iwura T, Torisu T, Goda Y, Uchiyama S (2017) Recent topics of research in the characterization and quality control of biopharmaceuticals in Japan. J Pharmaceut Sci 106:3431–3437Google Scholar
  25. Jimenez M, Rivas G, Minton AP (2007) Quantitative characterization of weak self-association in concentrated solutions of immunoglobulin G via the measurement of sedimentation equilibrium and osmotic pressure. Biochemistry 46:8373–8378.  https://doi.org/10.1021/bi7005515 CrossRefPubMedGoogle Scholar
  26. Kingsbury JS, Laue TM (2011) Fluorescence-detected sedimentation in dilute and highly concentrated solutions. Methods Enzymol 492:283–304.  https://doi.org/10.1016/B978-0-12-381268-1.00021-5 CrossRefPubMedGoogle Scholar
  27. Kingsbury JS, Laue TM, Chase SF, Connors LH (2012) Detection of high-molecular-weight amyloid serum protein complexes using biological on-line tracer sedimentation. Anal Biochem 425:151–156.  https://doi.org/10.1016/j.ab.2012.03.016 CrossRefPubMedPubMedCentralGoogle Scholar
  28. Krayukhina E, Uchiyama S (2016) Analytical ultracentrifugation. In: Senda T, Maenaka K (eds) Advanced methods in structural biology. Springer, Tokyo, pp 165–183CrossRefGoogle Scholar
  29. Krayukhina E, Uchiyama S, Nojima K, Okada Y, Hamaguchi I, Fukui K (2013) Aggregation analysis of pharmaceutical human immunoglobulin preparations using size-exclusion chromatography and analytical ultracentrifugation sedimentation velocity. J Biosci Bioeng 115:104–110.  https://doi.org/10.1016/j.jbiosc.2012.07.021 CrossRefPubMedGoogle Scholar
  30. Krayukhina E, Tsumoto K, Uchiyama S, Fukui K (2015) Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins. J Pharm Sci 104:527–535.  https://doi.org/10.1002/jps.24184 CrossRefPubMedGoogle Scholar
  31. Krayukhina E, Noda M, Ishii K, Maruno T, Wakabayashi H, Tada M, Suzuki T, Ishii-Watabe A, Kato M, Uchiyama S (2017) Analytical ultracentrifugation with fluorescence detection system reveals differences in complex formation between recombinant human TNF and different biological TNF antagonists in various environments. MAbs 9:664–679.  https://doi.org/10.1080/19420862.2017.1297909 CrossRefPubMedPubMedCentralGoogle Scholar
  32. Kress C, Sadowski G, Brandenbusch C (2016) Novel displacement agents for aqueous 2-phase extraction can be estimated based on hybrid shortcut calculations. J Pharm Sci 105:3030–3038.  https://doi.org/10.1016/j.xphs.2016.06.006 CrossRefPubMedGoogle Scholar
  33. Kroe RR, Laue TM (2009) NUTS and BOLTS: applications of fluorescence-detected sedimentation. Anal Biochem 390:1–13.  https://doi.org/10.1016/j.ab.2008.11.033 CrossRefPubMedGoogle Scholar
  34. Lebowitz J, Lewis MS, Schuck P (2002) Modern analytical ultracentrifugation in protein science: a tutorial review. Protein Sci 11:2067–2079.  https://doi.org/10.1110/ps.0207702 CrossRefPubMedPubMedCentralGoogle Scholar
  35. Liu J, Nguyen MD, Andya JD, Shire SJ (2005) Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution. J Pharm Sci 94:1928–1940.  https://doi.org/10.1002/jps.20347 CrossRefPubMedGoogle Scholar
  36. Liu J, Andya JD, Shire SJ (2006) A critical review of analytical ultracentrifugation and field flow fractionation methods for measuring protein aggregation. AAPS J 8:E580–E589.  https://doi.org/10.1208/aapsj080367 CrossRefPubMedPubMedCentralGoogle Scholar
  37. MacGregor IK, Anderson AL, Laue TM (2004) Fluorescence detection for the XLI analytical ultracentrifuge. Biophys Chem 108:165–185.  https://doi.org/10.1016/j.bpc.2003.10.018 CrossRefPubMedGoogle Scholar
  38. Narhi LO, Schmit J, Bechtold-Peters K, Sharma D (2012) Classification of protein aggregates. J Pharm Sci 101:493–498.  https://doi.org/10.1002/jps.22790 CrossRefPubMedGoogle Scholar
  39. Nishi H, Miyajima M, Nakagami H, Noda M, Uchiyama S, Fukui K (2010) Phase separation of an IgG1 antibody solution under a low ionic strength condition. Pharm Res 27:1348–1360.  https://doi.org/10.1007/s11095-010-0125-7 CrossRefPubMedGoogle Scholar
  40. Pekar A, Sukumar M (2007) Quantitation of aggregates in therapeutic proteins using sedimentation velocity analytical ultracentrifugation: practical considerations that affect precision and accuracy. Anal Biochem 367:225–237.  https://doi.org/10.1016/j.ab.2007.04.035 CrossRefPubMedGoogle Scholar
  41. Philo JS (2006) Is any measurement method optimal for all aggregate sizes and types? AAPS J 8:E564–E571.  https://doi.org/10.1208/aapsj080365 CrossRefPubMedPubMedCentralGoogle Scholar
  42. Philo JS (2009) A critical review of methods for size characterization of non-particulate protein aggregates. Curr Pharm Biotechnol 10:359–372CrossRefPubMedGoogle Scholar
  43. Rosenberg AS (2006) Effects of protein aggregates: an immunologic perspective. AAPS J 8:E501–E507.  https://doi.org/10.1208/aapsj080359 CrossRefPubMedPubMedCentralGoogle Scholar
  44. Saito S, Uchiyama S (2016) Biopharmaceutical evaluation of intermolecular interactions by AUC-SE. In: Uchiyama S, Arisaka F, Stafford W, Laue T (eds) Analytical Ultracentrifugation. Springer, Tokyo, pp 419–440CrossRefGoogle Scholar
  45. Schuck P (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys J 78:1606–1619.  https://doi.org/10.1016/S0006-3495(00)76713-0 CrossRefPubMedPubMedCentralGoogle Scholar
  46. Stafford W (2016) Analysis of nonideal, interacting, and noninteracting systems by sedimentation velocity analytical ultracentrifugation. In: Uchiyama S, Arisaka F, Stafford W, Laue T (eds) Analytical ultracentrifugation. Springer, Tokyo, pp 463–482CrossRefGoogle Scholar
  47. Uchiyama S (2014) Liquid formulation for antibody drugs. Biochim Biophys Acta 1844:2041–2052.  https://doi.org/10.1016/j.bbapap.2014.07.016 CrossRefPubMedGoogle Scholar
  48. Wafer L, Kloczewiak M, Luo Y (2016) Quantifying trace amounts of aggregates in biopharmaceuticals using analytical ultracentrifugation sedimentation velocity: Bayesian analyses and F statistics. AAPS J 18:849–860.  https://doi.org/10.1208/s12248-016-9925-y CrossRefPubMedGoogle Scholar
  49. Zhao H, Berger AJ, Brown PH, Kumar J, Balbo A, May CA, Casillas E Jr, Laue TM, Patterson GH, Mayer ML, Schuck P (2012) Analysis of high-affinity assembly for AMPA receptor amino-terminal domains. J Gen Physiol 139:371–388.  https://doi.org/10.1085/jgp.201210770 CrossRefPubMedPubMedCentralGoogle Scholar
  50. Zhao H, Casillas E Jr, Shroff H, Patterson GH, Schuck P (2013a) Tools for the quantitative analysis of sedimentation boundaries detected by fluorescence optical analytical ultracentrifugation. PLoS ONE 8:e77245.  https://doi.org/10.1371/journal.pone.0077245 CrossRefPubMedPubMedCentralGoogle Scholar
  51. Zhao H, Lomash S, Glasser C, Mayer ML, Schuck P (2013b) Analysis of high affinity self-association by fluorescence optical sedimentation velocity analytical ultracentrifugation of labeled proteins: opportunities and limitations. PLoS ONE 8:e83439.  https://doi.org/10.1371/journal.pone.0083439 CrossRefPubMedPubMedCentralGoogle Scholar
  52. Zhao H, Ma J, Ingaramo M, Andrade E, MacDonald J, Ramsay G, Piszczek G, Patterson GH, Schuck P (2014a) Accounting for photophysical processes and specific signal intensity changes in fluorescence-detected sedimentation velocity. Anal Chem 86:9286–9292.  https://doi.org/10.1021/ac502478a CrossRefPubMedPubMedCentralGoogle Scholar
  53. Zhao H, Mayer ML, Schuck P (2014b) Analysis of protein interactions with picomolar binding affinity by fluorescence-detected sedimentation velocity. Anal Chem 86:3181–3187.  https://doi.org/10.1021/ac500093m CrossRefPubMedPubMedCentralGoogle Scholar
  54. Zhao H, Fu Y, Glasser C, Andrade Alba EJ, Mayer ML, Patterson G, Schuck P (2016) Monochromatic multicomponent fluorescence sedimentation velocity for the study of high-affinity protein interactions. Elife 5. doi: https://doi.org/10.7554/eLife.17812

Copyright information

© International Union for Pure and Applied Biophysics (IUPAB) and Springer-Verlag GmbH Germany, part of Springer Nature 2017

Authors and Affiliations

  1. 1.Department of Biotechnology, Graduate School of EngineeringOsaka UniversityOsakaJapan
  2. 2.U-Medico Inc.OsakaJapan

Personalised recommendations